Literature DB >> 33040786

MiRNA-214 promotes the pyroptosis and inhibits the proliferation of cervical cancer cells via regulating the expression of NLRP3.

Shunrui Yu1, Na Zhao1, Mengya He1, Kai Zhang1, Xuehui Bi2.   

Abstract

Inflammasome mediates the maturation of interleukin-1β (IL-1β) and IL-18, triggers the pyroptosis and associates with multiple autoimmune diseases. In light of this, we hope to investigate the regulatory role of miRNA-214 in the inflammasome of cervical cancer. With the samples collected from 50 cervical cancer patients and 50 age-matched healthy subjects, real-time PCR and Western blotting were employed to detect the mRNA and/or protein expression profiles of the NOD-like receptor protein family, including NLRP1, NLRP3, NLRC4, Caspase-1, IL-1β, IL-18 and miR-214. Corresponding plasmids were used to transfect the Hela, HCC94, Siha or HUCEL normal cell lines to upregulate or downregulate the expression of targeted genes and to construct the cervical cancer models on rats. In addition, RT-PCR and Western blot were also considered to detect the expression of miR-214 and pyroptosis-related genes, while the pyroptosis of cells was evaluated by using the caspase-1 activity detection kit. Downregulation of miR-214 was found in the cervical cancer patients and the cervical cancer cell lines (** P <0.01), while overexpression of miR-214 could induce the pyroptosis of cervical cancer cell by targeting NLRP3. In cervical cancer patients, miR-214 and NLRP3 are downregulated, while upregulation of miR-214, by enhancing the expression of NLRP3, can advance the pyroptosis of cervical cancer cells. In addition, we, for the first time, clarify the correlation of cervical cancer with the miR-214 and NLRP3.

Entities:  

Keywords:  Cell pyroptosis; Cervical cancer; Inflammasome; NLRP3.; miR-214

Mesh:

Substances:

Year:  2020        PMID: 33040786

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  6 in total

1.  A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer.

Authors:  Haoran Hu; Meiqin Yang; Wei Dong; Bo Yin; Jianyi Ding; Baoyou Huang; Qingliang Zheng; Fang Li; Lingfei Han
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

2.  A Bibliometric Analysis of Pyroptosis From 2001 to 2021.

Authors:  Dan Ma; Bin Yang; Baoyi Guan; Luxia Song; Qiyu Liu; Yixuan Fan; Lin Zhao; Tongxin Wang; Zihao Zhang; Zhuye Gao; Siming Li; Hao Xu
Journal:  Front Immunol       Date:  2021-08-18       Impact factor: 7.561

Review 3.  Role of Pyroptosis in Gynecological Oncology and Its Therapeutic Regulation.

Authors:  Yi Huang; Ruiyun Li; Yuan Yang
Journal:  Biomolecules       Date:  2022-07-01

Review 4.  Noncoding RNAs in pyroptosis and cancer progression: Effect, mechanism, and clinical application.

Authors:  Menghui Zhang; Pengyuan Dang; Yang Liu; Bingbing Qiao; Zhenqiang Sun
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

5.  PEG2-Induced Pyroptosis Regulates the Expression of HMGB1 and Promotes hEM15A Migration in Endometriosis.

Authors:  Yi Huang; Ruiyun Li; Rui Hu; Jia Yao; Yuan Yang
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

6.  Circular RNA circ_0000228 promotes the malignancy of cervical cancer via microRNA-195-5p/ lysyl oxidase-like protein 2 axis.

Authors:  Shimei Liu; Bingqing Li; Ying Li; Huaihua Song
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.